Jeff Burbank
Chief Strategy & Transformation Officer
Fresenius Medical Care North America

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Read our cookie policy.
Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Chief Strategy & Transformation Officer
Fresenius Medical Care North America
Jeff Burbank has been chief executive officer and a director of NxStage since he founded the company in 1998. He has more than thirty years of in-depth management experience with companies developing, marketing, and manufacturing products for end stage renal disease (ESRD) patients. He has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering, and the acquisition of Medisystems Corporation, the evolution of the product line, and entry into services.
Prior to founding NxStage, Jeff cofounded Vasca, Inc., a company providing innovative implantable access devices, where he was president and chief executive officer, as well as chairman of its board of directors. He gained significant renal industry experience during his nine years in the renal division at Gambro, Inc., a medical technology company, where his last position was director of marketing and Advanced Technologies.
During his career, Jeff has been an inventor on more than fifty US patents for medical devices. He brings entrepreneurial skill, leadership, and technical and medical device experience in the renal dialysis industry to the board.
© 2006-2020, Fresenius Medical Care, All Rights Reserved